Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group LSE:VEC London Ordinary Share GB00B01D1K48 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.90p +0.79% 114.40p 113.90p 114.10p 114.90p 111.70p 112.40p 1,288,015 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 126.5 -40.1 -5.3 - 777.17

Vectura Share Discussion Threads

Showing 5851 to 5874 of 5875 messages
Chat Pages: 235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
19/7/2017
19:58
HBM had no holding in Ventura prior to merger and took a large cash option also in the merger .Not been on to HBM website recently but they had sold around ten million shares in the 9month period to end of march 2017. They are probably unimpressed with lack of communication from this management team like most investors .
best1467
19/7/2017
17:40
Nobody other than those engaged behind the scenes knows what is going on and too speculate on a public forum is meaningless.
dstorey1
19/7/2017
12:02
Not until there are more cash generating products to underpin the valuation. The lack of news on the FDA stalling is disturbing!
fhmktg
19/7/2017
11:53
Absolutely I'm sure HBM 'encouraged' the merger. Whether they've now got cold feet and / or this is portfolio alignment who knows? The problem of course is that there doesn't appear to be a corporate buyer for the shares?
dunderheed
19/7/2017
11:47
Were they shareholders in both companies pre-merger and so ended up with a very large holding in VEC after the merger. That may have resulted in a shareholding that was greater than their investment guidelines allow for and required a sell-off. Just a thought!
popper joe
19/7/2017
10:48
Aceuk-can't tell how many shares they have sold but the percentage of their portfolio in VEC shares has gone from 16.1% to 8.5% in one year. There were a very major shareholder in SKP but don't seem as enthusiastic about VEC.
alexchry
19/7/2017
10:42
Tbh I haven't had time to read the report (still in my in-box) so have just posted up the link. If HBM are selling as you say then I would assume it is ongoing as I haven't seen any RNS advising thresholds crossed, which I assume they will have?
aceuk
19/7/2017
08:23
Aceuk-it seems that the report on HBM shows that they have unloaded a very large number of VEC shares. It would be interesting to know when they did this and whether they are continuing to unload. It would also be interesting to know whether the unloading was a reflection of their view on VEC's prospects or whether it was to give a bit more balance to their portfolio. Despite most analysts remaining bullish, there does seem to be a change of sentiment towards VEC, we could do with some good news to stop the rot but that has been in very short supply since the takeover/ merger.
alexchry
18/7/2017
14:00
http://www.edisoninvestmentresearch.com/research/report/hbm-healthcare-investments430541/full
aceuk
17/7/2017
15:32
Back to the old ways up AM down PM
pooroldboy55
10/7/2017
12:58
Would be nice if just one of the Directors would use there own money to buy some shares are they waiting for it to go lower .Some comment on share price from them would be nice!!!!!!!!!!!!!! but hey ho they are getting paid so stuff the share holders.
pooroldboy55
06/7/2017
11:04
This has been in a decline for two years now with lower lows tracking a trend line. It needs something significant, or a run of smaller positive outcomes for this to reverse. This is a £1bill company, to justify that we either need exponential growth, prospects of a block buster or profits of around £100 mill, they need to start demonstrating the future prospects here, and maybe their latest presentation is attempting to communicate that.
diesel
04/7/2017
14:26
Well if the Directors do ever get round to buying a few its always best to buy pm that's if they ever look that is. Now at a 4 year low!!!!!!!!!!!!!! perhaps they never do look, you would think they would as lest make a comment.
pooroldboy55
04/7/2017
11:57
pooroldboy55 - Agree no directors purchases at this level begs the question and their commitment.
a0148009
04/7/2017
11:11
Ok just to prove me wrong goes up but lets see what happens this afternoon
pooroldboy55
04/7/2017
08:55
Agree. Looks more and more to be going under a pound have the directors got there heads in the sand a share price which as almost halfed in 12 months and no comment from them. And none of them buying are they expecting the price to go lower still ?
pooroldboy55
03/7/2017
17:38
My frustration with the management is lack of communication of any detail of the issues you raised.
best1467
03/7/2017
08:57
a1ord53-I share some of your frustration about the things that have happened in the year or so since the merger. There has been little good news and some of that has been watered down from initial expectations. However, it is hard to put the blame on management for GSK stopping royalty payments and hence the litigation. It is also hard to blame management for the failure so far to get FDA approval for the Advair generic. There has always been a gap in Vectura's development plan before new products arrived and the Advair generic would have profitably covered this period. Now that there is uncertainty about when and whether the generic will ever be approved and the GSK litigation at the end of the year things look rather bleak in the short term.
alexchry
01/7/2017
16:24
a1ord53, you should probably sell your shares in VEC, they seem to be causing you a lot of stress.
popper joe
01/7/2017
00:17
Vec management are Bustards !!! I deeply regret to invest into these bunch of croocks company Its life , lost a tonnes of money Investors , be aware VEC is scam
a1ord53
30/6/2017
21:06
Still no news on the major issues of the last year no surprise there.This company shows no respect for its shareholders if you listened to the presentation you would have thought the last months had been a total success .They made no mention of the near 50% drop in the share price it's just the usual positive spin
best1467
29/6/2017
15:25
This is not anymore jam tomorrow - this jam yesterday . company of broken dreams and corrupted analysts paid for their recommendations. Woodford should ashamed to be major shareholder !!! IMO looks like scam - 15 p valuation for Advair turned into 60 p loss !!!
a1ord53
29/6/2017
14:16
they must be ready to be bought out at this price ??
9degrees
29/6/2017
09:07
pob-they said right at the start that there was nothing new being presented so all we got was a bullish presentation about how good the company and its products were, just like every other company presentation. There was nothing in the presentation to change significantly one's opinion of the company. I am hoping in the next year that the GSK litigation ends favourably and the Advair generic gets approval otherwise I think there will be a long wait for significant good news.
alexchry
Chat Pages: 235  234  233  232  231  230  229  228  227  226  225  224  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170722 14:45:14